Global Epstein Barr Virus Market Size
Epstein-Barr virus market was valued at US$ 1.54 billion globally in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.3% to reach US$ 2.48 billion by 2030.
Among the eight types of human herpes viruses, the Epstein-Barr virus is the most common type in humans. Most cases of infectious mononucleosis are caused by the Epstein-Barr virus (EBV). This virus has been associated with multiple sclerosis, gastric carcinoma, nasopharyngeal carcinoma, Burkitt lymphoma, Hodgkin lymphoma, and lymphomas in immunocompromised individuals. The Epstein-Barr virus has been linked in numerous studies to lupus and various lymphatic malignancies. Because the symptoms of this condition are similar to those of other illnesses, it can be not easy to diagnose. The symptoms of an EBV infection include fever, fatigue, sore throat, and enlarged liver. Through a blood test, Epstein-Barr virus antibodies can be found. Viral gene expression in existence requirements for the association of EBV with cancer include the presence of EBV in each tumor cell and evidence that the virus is clonal (or oligoclonal) in tumor cells.